Tempest Therapeutics, Inc. (TPST) DCF Valuation

Tempest Therapeutics, Inc. (TPST) Valoración de DCF

US | Healthcare | Biotechnology | NASDAQ
Tempest Therapeutics, Inc. (TPST) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Tempest Therapeutics, Inc. (TPST) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¡Mejore sus estrategias de inversión con la calculadora DCF de Tempest Therapeutics! Explore las finanzas genuinas de la tempestad, ajuste las proyecciones y gastos de crecimiento, y observe instantáneamente cómo estas modificaciones afectan el valor intrínseco de Tempest Therapeutics, Inc. (TPST).


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -43.5 -18.4 -25.7 -32.3 -28.8 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation 1.1 .8 1.3 1.8 .4 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -44.6 -19.2 -27.0 -34.1 -29.2 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 63.5 18.8 51.8 31.2 39.2 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 1.3 .3 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .7 1.6 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable 1.5 1.1 1.0 1.1 .8 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure -.4 -.1 -.1 -.6 -.2 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -44.6 -19.1 -28.2 -35.1 -29.2 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -43.7 -18.4 -27.8 -32.2 -29.2 -.8 .0 .0 .0 .0
WACC, % 6.39 6.37 6.39 6.39 6.39 6.38 6.38 6.38 6.38 6.38
PV UFCF
SUM PV UFCF -.8
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -1
Net Debt -19
Equity Value 18
Diluted Shares Outstanding, MM 15
Equity Value Per Share 1.15

What You Will Get

  • Genuine Tempest Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures for Tempest Therapeutics, Inc. (TPST).
  • Comprehensive Customization: Modify all essential parameters (yellow cells) such as WACC, growth %, and tax rates easily.
  • Immediate Valuation Adjustments: Automatic recalculations to assess the effects of changes on Tempest Therapeutics’ fair value.
  • Flexible Excel Template: Designed for quick modifications, scenario analyses, and in-depth forecasts.
  • Efficient and Precise: Avoid building models from the ground up while ensuring accuracy and adaptability.

Key Features

  • Comprehensive TPST Data: Pre-filled with Tempest Therapeutics’ historical performance metrics and future projections.
  • Fully Customizable Inputs: Modify revenue growth rates, profit margins, discount rates, tax assumptions, and capital investments.
  • Dynamic Valuation Model: Instant updates to Net Present Value (NPV) and intrinsic value based on your adjustments.
  • Scenario Testing: Develop various forecast scenarios to explore different valuation possibilities.
  • User-Friendly Interface: Intuitive, organized, and crafted for both seasoned professionals and newcomers.

How It Works

  • Step 1: Download the prebuilt Excel template featuring Tempest Therapeutics, Inc. (TPST) data included.
  • Step 2: Navigate through the pre-filled sheets to grasp the essential metrics.
  • Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
  • Step 4: Instantly view recalculated results, including Tempest Therapeutics, Inc. (TPST) intrinsic value.
  • Step 5: Make informed investment decisions or create reports utilizing the outputs.

Why Choose This Calculator for Tempest Therapeutics, Inc. (TPST)?

  • Accurate Data: Up-to-date financials from Tempest Therapeutics ensure dependable valuation outcomes.
  • Customizable: Modify essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
  • Time-Saving: Pre-configured calculations save you from starting from square one.
  • Professional-Grade Tool: Tailored for investors, analysts, and consultants in the biotech sector.
  • User-Friendly: Simple design and clear instructions make it accessible for all users.

Who Should Use This Product?

  • Healthcare Investors: Develop comprehensive valuation models for analyzing investments in biotech.
  • Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the organization.
  • Consultants and Advisors: Deliver precise valuation insights for Tempest Therapeutics, Inc. (TPST) to clients.
  • Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling.
  • Biotech Enthusiasts: Gain insight into how biotech companies like Tempest Therapeutics, Inc. (TPST) are valued in the market.

What the Template Contains

  • Preloaded TPST Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.

No products were found matching.